[ad_1]
On Saturday, the US Food and Drug Administration granted emergency approval to use a treatment for Covid-19 developed by the biotech company “Regeneron.”
The approved drug was used to treat US President Donald Trump when he contracted COVID-19.
“France Press” quoted US Food and Drug Administration official Stephen Hahn as saying that “allowing these monoclonal antibody treatments can allow patients to avoid hospitalization and reduce the burden on our health care system.”
For his part, the general director of “Regeneron”, Leonard Schleifer, said that this constitutes “an important step in the fight against Covid-19, since high-risk patients in the United States will be able to obtain a promising treatment at the beginning of the course of infection “.
The green light was given to treat Regeneron, called Regen-Cove-2, which is a combination of two antibodies, after it was shown to reduce cases of Covid-19 that require hospitalization or emergency rooms.
The US company “Pfizer” and its German partner “Biontech” announced on Friday that they had submitted an application to the US Food and Drug Administration to approve the emergency use of the Covid-19 vaccine.
The companies expect the Food and Drug Administration to grant approval for emergency use in mid-December.
And they said they will begin shipping the doses immediately, knowing that Pfizer expects to have 50 million doses of vaccines ready this year, enough to protect 25 million people.
"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html ("Tweets from @tayyar_org"); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});
[ad_2]
